FIELD: chemical industry. SUBSTANCE: described is method of preparing compound (I) or salt thereof which comprises reducing compound of formula (II) in the presence of hydrogen, noble metal catalyst, and solvent. Also described are new intermediate compound of formula (II) and methods of preparing thereof. EFFECT: good yield and high degree of purity the desired product. 14 cl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 5-HETEROCYCLO-1,5-BENZODIAZEPINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1995 |
|
RU2152939C1 |
| DERIVATIVES OF 3-(5-TETRAZOLYLBENZYL)-AMINOPIPERIDINE, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2136675C1 |
| DERIVATIVES OF LACTAM AND PHARMACEUTICAL COMPOSITION BEING ANTAGONIST OF 5-OXYTRAPTAMINE(5-HT) FOR 5-HT RECEPTORS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND SOLVATES | 1992 |
|
RU2067980C1 |
| DERIVATIVES OF 1,5-BENZODIAZEPINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION CONTAINING ON SAID | 1994 |
|
RU2135486C1 |
| LACTAM DERIVATIVE OF PHYSIOLOCICALLY ACCEPTABLE SALTS OR SOLVATES | 1992 |
|
RU2081117C1 |
| ACRIDINE DERIVATIVES, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OF PATIENTS WITH MALIGNANT TUMORS | 1992 |
|
RU2119482C1 |
| 2,6-DIAMINOPURINE--β--D-RIBOFURANURONAMIDE DERIVATIVES, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION FOR SUPPRESSING ACTIVITY OF LEUKOCYTES, METHOD OF PREPARING PHARMACEUTICAL COMPOSITION, AND METHOD OF SUPPRESSING LEUKOCYTES | 1994 |
|
RU2129561C1 |
| TREATMENT METHOD | 2012 |
|
RU2621148C2 |
| HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
| METHODS FOR PREPARING DERIVATIVES OF 1-[2-(BENZIMIDAZOL-1-YL)QUINOLIN-8-YL]PIPERIDIN-4-YLAMINE | 2004 |
|
RU2323214C2 |
